Pharming provides update on outstanding shares
(Thomson Reuters ONE) -
Leiden, The Netherlands, May 17, 2010. Biotech company Pharming Group NV
("Pharming") (NYSE Euronext: PHARM) today provided an update on its outstanding
number of shares.
As result of various conversion notices, totalling ?2.0 million, from the
January 2010 ?7.5 million Private Bonds, Pharming issued a total amount
6,256,028 ordinary shares in return for these conversions. These conversions
have reduced the nominal value of the Bonds bonds issued in January 2010 to ?4.8
million. As a result, Pharming's total number of outstanding ordinary shares is
currently 162,921,104.
About Pharming Group NV
Pharming Group NV is developing innovative products for the treatment of genetic
disorders, ageing diseases, specialty products for surgical indications, and
nutritional products. Pharming's lead product Rhucin® for acute attacks of
Hereditary Angioedema has passed clinical development stage and the Market
Authorization Application is under review with the European Medicines Agency.
Prodarsan® is in early stage clinical development for Cockayne Syndrome and
lactoferrin for use in food products. The advanced technologies of the Company
include innovative platforms for the production of protein therapeutics,
technology and processes for the purification and formulation of these products,
as well as technology in the field of DNA repair (via DNage). Additional
information is available on the Pharming website, http://www.pharming.com
This press release contains forward looking statements that involve known and
unknown risks, uncertainties and other factors, which may cause the actual
results, performance or achievements of the Company to be materially different
from the results, performance or achievements expressed or implied by these
forward looking statements.
Contact:
Ms. Marjolein van Helmond, Pharming Group NV, T: +31 (0)71 52 47 431 or +31 (0)6
109 299 54
[HUG#1416168]
Press Release (PDF): http://hugin.info/132866/R/1416168/366822.pdf
Unternehmensinformation / Kurzprofil:
Datum: 17.05.2010 - 08:01 Uhr
Sprache: Deutsch
News-ID 20946
Anzahl Zeichen: 0
contact information:
Town:
Leiden
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 210 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharming provides update on outstanding shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Pharming Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
